Be on top of World Pharma News
Want to place your News, Brand, Service, Product or Event in front of World Pharma News?
Contact us now.
Banner

Springer Healthcare Announces Agreement With ASCO®

Springer Healthcare, part of Springer Science+Business Media, has signed an extensive three-year reprints and sales agreement effective 1 January 2012 with the American Society of Clinical Oncology® (ASCO), the world's leading professional organization representing physicians who care for people with cancer.

"Springer Healthcare is a leader in global licensing sales and has a track record of producing materials that are of high quality and value," said Dr. Allen Lichter, Chief Executive Officer of ASCO. "We are looking forward to working with Springer Healthcare to further the reach of many of ASCO's educational resources, including our flagship journal, the Journal of Clinical Oncology and our practice management journal, the Journal of Oncology Practice."

Springer Healthcare will be the exclusive supplier of reprints from articles published in ASCO's Journal of Clinical Oncology and Journal of Oncology Practice for North and South America, most of Europe, India, and other territories. In addition, Springer Healthcare will be the exclusive representative for licensing of other ASCO educational resources including the ASCO Annual Meeting abstracts and Educational Book, Virtual Meeting content, symposia proceedings, patient materials, and ASCO University® - the Society's online learning environment.

Steve Entwistle, Vice President of Springer Healthcare, commented, "We are honored to be appointed by ASCO to represent their journal reprints business as well as their other prestigious content. We value our relationship with ASCO, and we appreciate the confidence that they are showing in us."

About Springer Healthcare
Springer Healthcare is a leading publisher of medical educational products and forms part of Springer Science+Business Media. Springer Healthcare has undergone significant growth in the past decade and has expanded rapidly, with global reach into all international markets and more than 150 employees worldwide. Springer Healthcare's focus is on meeting the communication and publishing needs of the international healthcare communities, with a growing portfolio of products, including MedWire News, strategic consultancy, event management, eBusiness products and services, as well as print and digital medical publishing.

About Springer Science+Business Media
Springer Science+Business Media is a leading global scientific publisher, delivering quality content through innovative information products and services. The company is also a trusted provider of local-language professional publications in Europe, especially in Germany and the Netherlands. In the science, technology and medicine (STM) sector, the group publishes about 2,000 journals and more than 7,000 new books per year, as well as the largest STM eBook Collection worldwide. Springer has operations in about 20 countries in Europe, the USA, and Asia, and has more than 5,500 employees. In 2010, it generated annual sales of approximately EUR 866 million.

World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

News in Pictures

http://www.worldpharmanews.com/components/com_gk3_photoslide/thumbs_big/9445461331.jpg

Abbott Launches New Psoriasisanswers.com Web site

August marks National Psoriasis Awareness Month, an opportunity to raise awareness about psoriasis, a skin disease that affects nearly 7.5 million Americans. For those living with this condition, finding information Read more

http://www.worldpharmanews.com/components/com_gk3_photoslide/thumbs_big/399322AstraZeneca_Headquarters.jpg

AstraZeneca Headquarters, London

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, Read more

http://www.worldpharmanews.com/components/com_gk3_photoslide/thumbs_big/280148roche_basel.jpg

Site Roche Basel

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in Read more

http://www.worldpharmanews.com/components/com_gk3_photoslide/thumbs_big/390839Gehry_Novartis.jpg

Gehry building, Novartis headquarters in Basel, Switzerland

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving Read more

http://www.worldpharmanews.com/components/com_gk3_photoslide/thumbs_big/240209GSK_Corporate.jpg

GSK Corporate HQ

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better Read more

http://www.worldpharmanews.com/components/com_gk3_photoslide/thumbs_big/200324sanofi_avenits.jpg

Sanofi-aventis Group head office

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: Read more

http://www.worldpharmanews.com/components/com_gk3_photoslide/thumbs_big/964792Boehringer_Ingelheim_Center.jpg

Boehringer Ingelheim Center, Ingelheim, Germany

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 Read more

http://www.worldpharmanews.com/components/com_gk3_photoslide/thumbs_big/164840Novo_Nordisk.jpg

Novo Nordisk's corporate headquarters in Bagsværd, Denmark

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth Read more

Sponsored Video 

Be on top of World Pharma News
Want to place your News, Brand, Service, Product or Event in front of World Pharma News?
Contact us now.